Related Experiment Videos
Interstitial lung disease in dermatomyositis: clinicopathological study.
The Journal of Rheumatology
|February 1, 1987
Summary
Interstitial lung disease is common in dermatomyositis patients, often leading to poor outcomes. Early detection and understanding this complication are crucial for managing polymyositis-dermatomyositis.
Area of Science:
- Rheumatology
- Pulmonology
- Immunology
Background:
- Polymyositis-dermatomyositis (PM-DM) is an idiopathic inflammatory myopathy.
- Interstitial lung disease (ILD) is a known complication, but its prevalence in DM requires further investigation.
Purpose of the Study:
- To determine the frequency of interstitial lung disease in patients with dermatomyositis (DM).
- To evaluate the clinical characteristics and prognostic significance of ILD in DM.
Main Methods:
- Retrospective analysis of 14 patients diagnosed with PM-DM.
- Roentgenographic, serological, and histological examination of lung involvement.
- Assessment of response to corticosteroid therapy and patient outcomes.
Main Results:
- Roentgenographic evidence of ILD was found in 9 out of 14 DM patients (64.3%).
- Histological findings revealed interstitial pneumonitis and fibrosis in all cases.
- Only one patient tested positive for anti-Jo-1 antibody.
- Corticosteroid therapy showed a poor response, with 67% of patients succumbing to respiratory failure.
Conclusions:
- Interstitial lung disease occurs more frequently in DM than previously reported.
- ILD in DM is associated with poor prognosis and high mortality.
- ILD should be considered an important prognostic factor in DM management.